Autopsy report · NCT03090334

A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis

“Insufficient rate of accrual due to the start of a concomitant similar study”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 34 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Bologna

Sponsor type

University, hospital or other

Conditions

Invasive Candidiases; Abdominal Infection

Interventions

De-escalation

Participants

34

Sites

1

Countries

Italy

Trials that died the same way

• Pre-operative Zoledronate in Triple Negative Breast Cancer
  “The study stopped prematurely due to the low accrual rate” (80% match in meaning)
• Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
  “the study had a low accrual rate” (77% match in meaning)
• High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
  “Insufficient rate of accrual” (75% match in meaning)
• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (73% match in meaning)
• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.